DR. PAUL ASHTON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2007-10-26 Dr. Ashton received a BSc (Hons) in chemistry from Durham University, England, and a PhD in pharmaceutical science from the University of Wales.

Data sourced from SEC filings. Last updated: 2026-03-05